1. 168 A novel prostate-restricted tumor-associated antigen: a potential therapeutic target. (10th December 2020) Authors: Lopez Bujanda, Zoila (Areli); Obradovic, Aleksandar; Nirschl, Thomas; O'Donnell, Timothy; Laserson, Uri; Macedo-Gonzales, Rodney; Reshef, Ran; Yuan, Tiezheng; Soni, Mithil; Antonarakis, Emmanuel; Larman, Benjamin; Muranski, Pawel; Drake, Charles; Lopez Bujanda, Zoila (Areli) Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 168 A novel prostate-restricted tumor-associated antigen: a potential therapeutic target. (9th November 2020) Authors: Lopez Bujanda, Zoila (Areli); Obradovic, Aleksandar; Nirschl, Thomas; O'Donnell, Timothy; Laserson, Uri; Macedo-Gonzales, Rodney; Reshef, Ran; Yuan, Tiezheng; Soni, Mithil; Antonarakis, Emmanuel; Larman, Benjamin; Muranski, Pawel; Drake, Charles; Lopez Bujanda, Zoila (Areli) Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A182 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy; Sachsenmeier, ... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy; Sachsenmeier, ... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two. Issue 1 (November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina; Bajaj, Anshika; Archer, Jacob; Reeves, Rebecca; Ngo, Lisa; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fuseri, Nicola... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two. Issue 1 (November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina; Bajaj, Anshika; Archer, Jacob; Reeves, Rebecca; Ngo, Lisa; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fuseri, Nicola... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 345 Phase 3 study of combination pembrolizumab + olaparib therapy versus enzalutamide/abiraterone in metastatic castration-resistant prostate cancer (mCRPC) after progression on chemotherapy (KEYLYNK-010). (10th December 2020) Authors: Yu, Evan; Park, Se Hoon; Huang, Yi-Hsiu; Bennamoun, Mostefa; Xu, Lu; Kim, Jeri; Antonarakis, Emmanuel Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A210 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 345 Phase 3 study of combination pembrolizumab + olaparib therapy versus enzalutamide/abiraterone in metastatic castration-resistant prostate cancer (mCRPC) after progression on chemotherapy (KEYLYNK-010). (9th November 2020) Authors: Yu, Evan; Park, Se Hoon; Huang, Yi-Hsiu; Bennamoun, Mostefa; Xu, Lu; Kim, Jeri; Antonarakis, Emmanuel Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A370 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Compositional differences in gastrointestinal microbiota in prostate cancer patients treated with androgen axis-targeted therapies. Issue 4 (November 2018) Authors: Sfanos, Karen; Markowski, Mark; Peiffer, Lauren; Ernst, Sarah; White, James; Pienta, Kenneth; Antonarakis, Emmanuel; Ross, Ashley Journal: Prostate cancer and prostatic diseases Issue: Volume 21:Issue 4(2018) Page Start: 539 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Immune response from STRIDE, a randomized, Phase II, open-label study of sipuleucel-T (sip-T) with concurrent vs sequential enzalutamide (enz) administration in metastatic castration-resistant prostate cancer (mCRPC). Issue 2 (December 2015) Authors: Drake, Charles; Quinn, David; Dreicer, Robert; Antonarakis, Emmanuel; Shore, Neal; Corman, John; Concepcion, Raoul; Pieczonka, Christopher; Campogan, Dwayne; Fan, Li-Qun; Chang, Nancy; Sheikh, Nadeem; Petrylak, Daniel Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗